Abstract
Aplastic anemia (AA) is a life-threatening bone marrow failure disorder, if untreated, is associated with very high mortality. Allogenic bone marrow transplantation (BMT) is the standard of care for severe aplastic anemia (SAA) patients those who are younger than 40 years of age. The development of secondary malignancies in post-BMT setting for AA is a rare, however, well documented phenomenon. Among the secondary malignancies, development of acute myeloid leukemia is even rarer entity. Here we report a case of acute myeloid leukemia following human leucocyte antigen (HLA) matched sibling peripheral blood stem cell transplant (PBSCT) in a case of SAA. The patient achieved complete remission (CR) following chemotherapy and in CR1, a second HLA matched PBSCT from a different donor was offered. The patient is presently in remission at day +180 post-PBSCT.
References
Deeg HJ, Socié G, Schoch G et al (1996) Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87:386–392
Otero L, de Souza DC, de Cássia Tavares R et al (2012) Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: report of a new case and review of the literature. Genet Mol Biol 35:734–736
Lawler M, Locasciulli A, Longoni D et al (2002) Leukemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anemia. Bone Marrow Transpl 29:453–456
Camitta BM, Rappeport JM, Parkman R et al (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 45:355–363
Marsh JC, Ball SE, Cavenagh J et al (2009) British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147:43–70
Kojima S, Ohara A, Tsuchida M, Japan Childhood Aplastic Anemia Study Group et al (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 100:786–790
Maciejewski JP, Risitano A, Sloand EM et al (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 99:3129–3135
Keung YK, Pettenati MJ, Cruz JM et al (2001) Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol 66:167–171
Varma N, Varma S, Movafagh A et al (1995) Unusual clonal cytogenetic abnormalities in aplastic anemia. Am J Hematol 49:256–257
Klingemann HG, Storb R, Sanders J et al (1986) Acute lymphoblastic leukaemia after bone marrow transplantation for aplastic anaemia. Br J Haematol 63:47–50
Haltrich I, Müller J, Szabó J et al (2003) Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet 142:124–128
Hashino S, Fujisawa F, Kondo T et al (2006) Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transplantation in a patient with severe-type aplastic anemia. Int J Hematol 84:363–366
Hughes RT, Milligan DW, Smith GM et al (1988) A second bone marrow transplant for acute myeloid leukaemia after transplantation for aplastic anaemia. Br J Haematol 68:391
Sevilla J, Querol S, Molines A et al (2006) Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol 77:259–263
Hamaki T, Kajiwara K, Kami M et al (2008) Donor cell-derived acute monoblastic leukemia involving MLL gene translocation in an adult patient who received umbilical cord blood transplantation. Bone Marrow Transplant 41:91–92
Browne PV, Lawler M, Humphries P et al (1991) Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med 325:710–713
Tallman MS, Rowlings PA, Milone G et al (2000) Effect of post-remission chemotherapy prior to HLA-identicalsibling transplantation for acute myelogenous leukemia in first complete remission. Blood 96:1254–1258
Rowe JM (2002) Therapy of secondary leukemia. Leukemia 16:748–750
Pagano L, Pulsoni A, Vignetti M et al (2005) Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials. Ann Oncol 16:228–233
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manivannan, P., Purohit, A., Somasundaram, V. et al. Leukemic Transformation of Severe Aplastic Anemia Following Matched Allogenic Stem Cell Transplantation, Transplanted Again in CR 1. Indian J Hematol Blood Transfus 32 (Suppl 1), 223–227 (2016). https://doi.org/10.1007/s12288-014-0484-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-014-0484-z